The antitumor effects of human lymphoblastoid interferon on human renal cell carcinoma in athymic nude mice Takashi YamaokaHiroshi TakadaYoshio Sakurai Original Articles Pages: 184 - 187
Prevention of cyclophosphamide-induced urotoxicity by reduced glutathione and its effect on acute toxicity and antitumor activity of the alkylating agent Odoardo TofanettiEnnio CavallettiFranco Zunino Original Articles Pages: 188 - 193
Identification of anthracycline analogues with enhanced cytotoxicity and lack of cross-resistance to adriamycin using a series of mammalian cell lines in vitro Bridget T. HillLorraine Y. DennisRichard D. H. Whelan Original Articles Pages: 194 - 201
Inhibition of growth of leukemic cells by inhibitors of calmodulin: Phenothiazines and melittin William N. HaitLinda GraisEd. C. Cadman Original Articles Pages: 202 - 205
Biologic and pharmacologic effects of harringtonine on human leukemia-lymphoma cells Yuzuru TakemuraTakao OhnumaJames F. Holland Original Articles Pages: 206 - 210
Small intestinal transit time affects methotrexate absorption in children with acute lymphoblastic leukemia A. D. J. PearsonA. W. CraftA. N. Campbell Original Articles Pages: 211 - 215
Phase-I–II study of high-dose melphalan and autologous marrow transplantation in adult patients with poor-risk non-Hodgkin's lymphomas B. MascretD. MaraninchiY. Carcassonne Original Articles Pages: 216 - 221
Hexamethylmelamine, adriamycin, and cyclophosphamide (HAC) versus cis-dichlorodiamineplatinum, adriamycin, and cyclophosphamide (PAC) in advanced ovarian cancer: A randomized clinical trial Cristiana SessaGiorgio BolisCostantino Mangioni Original Articles Pages: 222 - 228
Medroxyprogesterone acetate (MAP) and tamoxifen (TMX) plasma levels after simultaneous treatment with ‘low’ TMX and ‘high’ MAP doses Carlo M. CamaggiElena StrocchiFranco Pannuti Original Articles Pages: 229 - 231
Medroxyprogesterone acetate bioavailability after high-dose intraperitoneal administration in advanced cancer Carlo M. CamaggiElena StrocchiFranco Pannuti Original Articles Pages: 232 - 234
Methylprednisolone as an antiemetic drug D. SchallierS. Van BelleA. Willekens Original Articles Pages: 235 - 237
The distribution and elimination of methotrexate in mouse blood and brain after concurrent administration of polysorbate 80 M. Noor AzminJames F. B. StuartAlexander T. Florence Original Articles Pages: 238 - 242
Amelioration of doxorubicin-induced skin necrosis in mice by butylated hydroxytoluene J. Patrick DaughertyAtul Khurana Original Articles Pages: 243 - 246
Beta-2-microglobulin excretion: An indicator of long term nephrotoxicity during cis-platinum treatment? Peter Grundtvig SørensenMogens H. NissenMikael Rørth Original Articles Pages: 247 - 249
High-dose intravenous metoclopramide and intermittent intramuscular prochlorperazine and diazepam in the management of emesis induced by cis-dichlorodiammineplatinum D. M. LuesleyP. B. TerryK. K. Chan Original Articles Pages: 250 - 252
In vivo distribution studies of radioactively labelled platinum complexes; cis-dichlorodiammine platinum(II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (IV), cis-dichloro-bis-cyclopropylamine platinum(II), and cis-diammine 1,1-cyclobutanedicarboxylate platinum(II) in patients with malignant disease, using a gamma camera S. E. OwensN. ThatcherB. W. Fox Original Articles Pages: 253 - 257
Cis-dichlorodiammineplatinum (Cis-platinum) and etoposide (VP-16) in malignant lymphoma — an effective salvage regimen I. R. JudsonE. Wiltshaw Original Articles Pages: 258 - 261
The effect of captopril on renal function in patients during the first cis-diamminedichloroplatinum II infusion Joop J. G. OffermanDirk Th. SleijferAb J. M. Donker Original Articles Pages: 262 - 264
The clinical pharmacokinetics of the novel antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717) Dawn L. AlisonDavid R. NewellA. Hilary Calvert Original Articles Pages: 265 - 271
A randomised trial of tamoxifen versus tamoxifen with aminoglutethimide in post-menopausal women with advanced breast cancer R. MilstedT. HabeshawK. Calman Short Communication Pages: 272 - 273
A pharmacokinetic evaluation of IM administration of bleomycin oil suspension Margaret DavyElisabeth PausGustav Lehne Short Communication Pages: 274 - 276
Combination chemotherapy of advanced renal cell cancer with CCNU and vinblastine Hilde Heen SommerSophie Dorothea FossåHans Henrik Lien Short Communication Pages: 277 - 278
Melphalan-resistant multiple myeloma: results of treatment according to the M-2 protocol B. SteinkeF. W. BuschH. D. Waller Short Communication Pages: 279 - 281
Cyclic combination chemotherapy in advanced adenocarcinoma of the lung: Comparison of two FAM schedules W. K. LamS. Y. SoDonald Y. C. Yu Short Communication Pages: 282 - 283